Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon

The idiopathic inflammatory myopathies (IIM) until recently have been considered a heterogeneous broad group of six autoimmune muscle diseases. Initially, autoantibodies in IIM (including JDM) and CD8+ T cell-induced cytotoxicity (PM and IBM) were the predominant recognized etiopathology mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Patwardhan, Anjali, Spencer, Charles H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702719/
https://www.ncbi.nlm.nih.gov/pubmed/31429786
http://dx.doi.org/10.1186/s12969-019-0361-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702719/
https://www.ncbi.nlm.nih.gov/pubmed/31429786
http://dx.doi.org/10.1186/s12969-019-0361-2

Ejemplares similares